Clinical Trial: A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Randomized Comparison of Two Dosage Schedules of Intravitreal ISIS 2922 for Patients With Advanced Cytomegalovirus Retinitis

Brief Summary: The purpose of this study is to compare the safety and effectiveness of two dosage schedules for ISIS 2922 in the treatment of advanced cytomegalovirus (CMV) retinitis

Detailed Summary: This is a multicenter, prospective, randomized, open-label study comparing 2 dosage schedules of ISIS 2922.
Sponsor: Ionis Pharmaceuticals, Inc.

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: NIH AIDS Clinical Trials Information Service

Dates:
Date Received: November 2, 1999
Date Started:
Date Completion:
Last Updated: June 23, 2005
Last Verified: December 1998